Idm Pharma (IDMI) Inactive 10-K2006 FY Annual report

Filed: 2 Apr 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: accomplish, accomplished, adolescent, AICPA, analogue, bankruptcy, behavior, bifurcation, calendar, childhood, classification, COG, comparison, contractor, damage, doubt, eCTD, embedded, EU, explanatory, fileno, forfeiture, formula, FSP, gather, graph, hybrid, hypertension, hypo, identity, IDMPharma, immunostimulatory, indirectly, infrastructure, inRule, insert, Kalikrein, Los, MAA, Mepacttm, mifamurtide, moderate, myalgia, nausea, negligible, nonperformance, ODAC, ofFASB, ofRegulation, onForm, onpage, outlined, outweigh, package, panel, pediatric, peer, pegylated, Pharm, pharmacokinetic, pharmacovigilance, plain, POG, poster, prominent, pronouncement, purity, rata, reallocated, reinvested, remeasurement, requisite, restart, Retrospective, revaluation, revalued, SAB, seasoned, segregated, settlement, shell, soliciting, spurt, strength, submittal, successor, tachycardia, thisForm, underEITF, unrecognized, unresectable, vanilla, vivogeneration, vomiting, withEITF

Removed: abdication, accelerate, accept, accommodate, Achillion, acted, advance, advisor, aerospace, age, Aggregated, analyze, Ansan, assist, attended, auditor, awarded, aware, Basel, billed, bind, BioChem, cardiovascular, certificate, Chairman, charter, clearance, comer, commenced, compensated, compounded, consent, consortium, constitute, contrary, Controller, culminating, Cytel, daily, delegate, delegated, device, diligence, displayed, dispose, disregard, dupont, duty, Emile, employed, empowered, encountered, enhanced, equitable, faith, fiduciary, financed, founder, fullest, funded, furnish, Glaxo, greene, Hibon, howard, improper, inattention, incorporation, indemnification, indemnify, inducement, inflammation, injunction, integrated, intentional, joining, jr, Kaiser, led, loyalty, membership, merged, Merieux, misconduct, monetary, monthly, Newman, nominating, nominee, optionee, page, participated, pattern, Pharmacia, phone, plc, pledge, prepayment, presence, projection, promissory, realizable, relationship, relief, repeat, requested, Rollmet, scheduling, Scientist, serve, served, show, surrendered, sustained, temporary, thereof, thereunder, thousand, Trega, unexcused, unexercisable, vaere, venture, viral, Vista, william

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

IDMI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements on Form S-3 (No.’s 333-141472, 333-128990, 333-114793, 333-109641 and 333-76544) of IDM Pharma, Inc. and in the related Prospectuses and in the Registration Statements on Form S-8 (No.’s 333-136647, 333-128178, 333-117116, 333-107416, 333-87266, 333-64238, 333-63950, 333-44852, 333-87759, 333-62437, 333-11577) pertaining to the 1989 Stock Plan, As Amended, 1994 Non-Employee Directors’ Stock Option Plan, As Amended, 1997 Stock Option Plan, 2000 Stock Plan, As Amended, 2001 Employee Stock Purchase Plan, As Amended, Employee Stock Purchase Plan For Employees Of IDM S.A., the IDM Pharma, Inc. Option Liquidity Agreements and the 2001 Restricted Stock Purchase Agreement of IDM Pharma, Inc., and of our report dated March 28, 2007, with respect to the consolidated financial statements of IDM Pharma, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2006.



	/s/ Ernst & Young LLP

Los Angeles, California
March 28, 2007